SMTL ID : 3dd1.1

Crystal structure of glycogen phophorylase complexed with an anthranilimide based inhibitor GSK254

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.57 Å

Oligo State

homo-dimer

Ligands

2 x NBG: N-acetyl-beta-D-glucopyranosylamine(Non-covalent)

NBG.1: 15 residues within 4Å: Chain A: G.137, L.138, L.141, N.286, D.341, H.379, T.380, V.457, N.486, Y.575, E.674, A.675, S.676, G.677, T.678 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:T.380 Hydrogen bonds: A:L.138, A:N.286, A:N.286, A:H.379, A:H.379, A:N.486, A:N.486, A:E.674, A:E.674, A:S.676, A:G.677, A:G.677 Water bridges: A:N.286, A:A.675, A:A.675, A:T.678 NBG.8: 13 residues within 4Å: Chain B: G.137, L.138, N.286, D.341, H.379, V.457, N.486, Y.575, E.674, A.675, S.676, G.677, T.678 12 PLIP interactions: 12 interactions with chain B Hydrogen bonds: B:L.138, B:N.286, B:N.286, B:H.379, B:N.486, B:N.486, B:Y.575, B:E.674, B:S.676, B:G.677, B:G.677 Water bridges: B:N.286

2 x PLP: PYRIDOXAL-5'-PHOSPHATE(Covalent)

PLP.2: 16 residues within 4Å: Chain A: Y.92, G.136, G.137, W.493, V.569, K.570, K.576, Y.650, R.651, V.652, A.655, Q.667, G.677, T.678, G.679, K.682 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:Y.92, A:Y.650, A:V.652, A:K.682 Hydrogen bonds: A:T.678, A:T.678, A:T.678, A:G.679 Water bridges: A:G.137, A:K.570, A:K.576, A:N.680, A:N.680 Salt bridges: A:K.570, A:K.576 PLP.9: 15 residues within 4Å: Chain B: Y.92, G.136, G.137, W.493, V.569, K.570, K.576, Y.650, R.651, V.652, A.655, G.677, T.678, G.679, K.682 15 PLIP interactions: 15 interactions with chain B Hydrophobic interactions: B:Y.92, B:Y.650, B:K.682 Hydrogen bonds: B:Y.650, B:T.678, B:T.678, B:G.679 Water bridges: B:Y.92, B:G.137, B:K.570, B:K.570, B:K.576, B:N.680 Salt bridges: B:K.570, B:K.576

2 x CFF: CAFFEINE(Non-covalent)

CFF.3: 6 residues within 4Å: Chain A: N.284, F.287, H.573, A.612, G.614, Y.615 3 PLIP interactions: 3 interactions with chain A pi-Stacking: A:F.287, A:F.287, A:Y.615 CFF.10: 6 residues within 4Å: Chain B: N.284, F.287, H.573, A.612, G.614, Y.615 4 PLIP interactions: 4 interactions with chain B Water bridges: B:H.616 pi-Stacking: B:F.287, B:F.287, B:Y.615

2 x 25D: 2-cyclohexyl-N-[(3-{[(2,4,6-trimethylphenyl)carbamoyl]amino}naphthalen-2-yl)carbonyl]-D-alanine(Non-covalent)

25D.4: 17 residues within 4Å: Chain A: W.69, I.70, Q.73, Q.74, Y.77, Y.157, R.195, F.198, D.229, T.242, R.244, R.312, A.315 Chain B: V.42, K.43, D.44, V.47 22 PLIP interactions: 17 interactions with chain A, 5 interactions with chain B Hydrophobic interactions: A:W.69, A:Q.73, A:Q.73, A:Q.74, A:Q.74, A:Y.77, A:F.198, A:T.242, A:A.315, B:K.43, B:V.47, B:V.47 Hydrogen bonds: A:Q.73, A:R.195, B:V.42, B:D.44 Water bridges: A:Q.73, A:R.83 Salt bridges: A:R.83, A:R.312 pi-Stacking: A:W.69 pi-Cation interactions: A:R.195 25D.13: 16 residues within 4Å: Chain A: V.42, K.43, D.44, V.47 Chain B: W.69, I.70, Q.73, Q.74, R.195, F.198, D.229, T.242, R.244, R.311, R.312, A.315 15 PLIP interactions: 11 interactions with chain B, 4 interactions with chain A Hydrophobic interactions: B:W.69, B:Q.73, B:Q.73, B:Q.74, B:Q.74, B:F.198, B:T.242, B:A.315, A:D.44, A:V.47 Hydrogen bonds: B:Q.73, A:V.42, A:D.44 Salt bridges: B:R.312 pi-Cation interactions: B:R.195

5 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)

MPD.5: 3 residues within 4Å: Chain A: H.203, W.217, R.353 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:W.217 Water bridges: A:W.217 MPD.6: 4 residues within 4Å: Chain A: A.324, I.358, E.359, K.360 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:E.359 MPD.7: 3 residues within 4Å: Chain A: K.731, D.748, F.768 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:K.731, A:F.768 MPD.14: 2 residues within 4Å: Chain B: Y.728, D.771 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:Y.728 MPD.15: 1 residues within 4Å: Chain B: W.176 No protein-ligand interaction detected (PLIP)

2 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)

MES.11: 6 residues within 4Å: Chain B: I.172, R.173, D.174, G.175, E.554, E.648 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:G.175 Water bridges: B:D.174 Salt bridges: B:E.648 MES.12: 7 residues within 4Å: Chain B: R.51, R.95, E.126, I.127, E.128, E.129, R.651 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:R.95, B:R.651 Salt bridges: B:R.51, B:E.129

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Thomson, S.A. et al., Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy. Bioorg.Med.Chem.Lett. (2009)

Release Date

2009-04-21

Peptides

Glycogen phosphorylase, liver form: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Glycogen phosphorylase, liver form

Related Entries With Identical Sequence